Mehdi H. Shishehbor, DO

Mehdi H. Shishehbor, DO
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Carlos Alves, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Vivek Rajagopal, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Mehdi H. Shishehbor, DO, MPH, Cleveland Clinic, 9500 Euclid Avenue, JJ40, Cleveland, OH 44195; shishem@gmail.com

All authors reported that they have no financial relationships that pose a potential conflict of interest with this article.

Dr. Shishehbor is supported in part by the National Institutes of Health, National Institute of Child Health and Human Development, Multidisciplinary Clinical Research Career Development Programs Grant K12 HD049091, and the NIH Loan Repayment Program.

Mehdi H. Shishehbor, DO
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Carlos Alves, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Vivek Rajagopal, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Mehdi H. Shishehbor, DO, MPH, Cleveland Clinic, 9500 Euclid Avenue, JJ40, Cleveland, OH 44195; shishem@gmail.com

All authors reported that they have no financial relationships that pose a potential conflict of interest with this article.

Dr. Shishehbor is supported in part by the National Institutes of Health, National Institute of Child Health and Human Development, Multidisciplinary Clinical Research Career Development Programs Grant K12 HD049091, and the NIH Loan Repayment Program.

Mehdi H. Shishehbor, DO
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Carlos Alves, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Vivek Rajagopal, MD
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Mehdi H. Shishehbor, DO, MPH, Cleveland Clinic, 9500 Euclid Avenue, JJ40, Cleveland, OH 44195; shishem@gmail.com

All authors reported that they have no financial relationships that pose a potential conflict of interest with this article.

Dr. Shishehbor is supported in part by the National Institutes of Health, National Institute of Child Health and Human Development, Multidisciplinary Clinical Research Career Development Programs Grant K12 HD049091, and the NIH Loan Repayment Program.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hazens@ccf.org

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hazens@ccf.org

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail hazens@ccf.org

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular CREDIT Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org

Mehdi H. Shishehbor, DO
Department of Internal Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular CREDIT Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org

Mehdi H. Shishehbor, DO
Department of Internal Medicine, The Cleveland Clinic

Deepak L. Bhatt, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular CREDIT Medicine, The Cleveland Clinic

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org